Table 1 Comparative analysis of 18 consecutive patients with strabismus secondary to retinoblastoma. Patients’ demographics and treatment features
No. | Age at tumor presentation (months) | Sex | Laterality | Affected eye tumor group | Macular involvement | Chemotherapy | Intra vitreous chemotherapy | Adjuvant therapy |
|---|---|---|---|---|---|---|---|---|
1 | 8 | F | OS | C | Yes | IAC*1 | − | − |
2 | 9 | F | OU | D | Yes | IVC*16 | − | + |
3 | 10 | M | OU | D | Yes | IVC*8 | − | + |
4 | 2 | M | OU | D | No | IAC*3 | − | + |
5 | 20 | M | OD | D | Yes | IVC*8 | + | + |
6 | 6 | M | OU | C | No | IVC*8 | − | + |
7 | 20 | F | OS | E | Yes | IAC*3/IVC*12 | − | + |
8 | 6 | F | OU | B | Yes | IVC*8 | − | + |
9 | 39 | M | OD | D | No | IAC*2 | − | − |
10 | 27 | F | OS | D | No | IAC*3 | + | − |
11 | 24 | F | OU | B | Yes | IVC*6 | − | + |
12 | 7 | M | OS | C | No | IAC*2 | − | + |
13 | 11 | F | OD | D | Yes | IAC*4/IVC*8 | − | + |
14 | 5 | F | OU | D | Yes | IVC*8 | − | + |
15 | 8 | F | OU | C | Yes | IVC*12 | + | + |
16 | 12 | M | OS | D | No | IAC*2 | + | − |
17 | 14 | M | OS | D | Yes | IAC*2 | + | − |
18 | 12 | F | OD | D | yes | IAC*1/IVC*8 | + | + |